(Q43629230)
Statements
1 reference
A phase II trial of dual protease inhibitor therapy: amprenavir in combination with indinavir, nelfinavir, or saquinavir (English)
1 reference
Eron JJ
1 reference
Haubrich R
1 reference
Lang W
1 reference
Pagano G
1 reference
Millard J
1 reference
Wolfram J
1 reference
Snowden W
1 reference
Pedneault L
1 reference
Tisdale M
1 reference
1 April 2001
1 reference
1 reference
26
1 reference
5
1 reference
458-461
1 reference
Identifiers
1 reference
1 reference